Biocept Inc sees poster at ASCO spotlight impressive performance of its CNSide assay compared to cytology in detecting a type of cancer
Biocept Inc (NASDAQ:BIOC) said that a poster presentation at the annual American Society of Clinical Oncology (ASCO) demonstrates the impressive ability of...